|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Franceschi S, Talamini R, Barra S, Baron
AE, Negri E, Bidoli E, Serraino D and La Vecchia C: Smoking and
drinking in relation to cancers of the oral cavity, pharynx,
larynx, and esophagus in northern Italy. Cancer Res. 50:6502–6507.
1990.PubMed/NCBI
|
|
4
|
Ang KK and Sturgis EM: Human
papillomavirus as a marker of the natural history and response to
therapy of head and neck squamous cell carcinoma. Semin Radiat
Oncol. 22:128–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaturvedi AK: Epidemiology and clinical
aspects of HPV in head and neck cancers. Head Neck Pathol. 6(Suppl
1): S16–S24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chaturvedi AK, Engels EA, Pfeiffer RM,
Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, et al: Human papillomavirus and rising oropharyngeal
cancer incidence in the United States. J Clin Oncol. 29:4294–4301.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brouwer AF, Eisenberg MC and Meza R: Age
effects and temporal trends in HPV-Related and HPV-Unrelated oral
cancer in the United States: A multistage carcinogenesis modeling
analysis. PLoS One. 11:e01510982016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fakhry C, Westra WH, Li S, Cmelak A, Ridge
JA, Pinto H, Forastiere A and Gillison ML: Improved survival of
patients with human papillomavirus-positive head and neck squamous
cell carcinoma in a prospective clinical trial. J Natl Cancer Inst.
100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu C, Mann D, Sinha UK and Kokot NC: The
molecular mechanisms of increased radiosensitivity of HPV-positive
oropharyngeal squamous cell carcinoma (OPSCC): An extensive review.
J Otolaryngol Head Neck Surg. 47:592018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: Pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barboro P, Ferrari N and Balbi C: Emerging
roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in
cancer progression. Cancer Lett. 352:152–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gallardo M, Hornbaker MJ, Zhang X, Hu P,
Bueso-Ramos C and Post SM: Aberrant hnRNP K expression: All roads
lead to cancer. Cell Cycle. 15:1552–1557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bomsztyk K, Denisenko O and Ostrowski J:
hnRNP K: One protein multiple processes. Bioessays. 26:629–638.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carpenter B, McKay M, Dundas SR, Lawrie
LC, Telfer C and Murray GI: Heterogeneous nuclear ribonucleoprotein
K is over expressed, aberrantly localised and is associated with
poor prognosis in colorectal cancer. Br J Cancer. 95:921–927. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen LC, Chung IC, Hsueh C, Tsang NM, Chi
LM, Liang Y, Chen CC, Wang LJ and Chang YS: The antiapoptotic
protein, FLIP, is regulated by heterogeneous nuclear
ribonucleoprotein K and correlates with poor overall survival of
nasopharyngeal carcinoma patients. Cell Death Differ. 17:1463–1473.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu CS, Chang KP, Chen LC, Chen CC, Liang
Y, Hseuh C and Chang YS: Heterogeneous ribonucleoprotein K and
thymidine phosphorylase are independent prognostic and therapeutic
markers for oral squamous cell carcinoma. Oral Oncol. 48:516–522.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Gu P, Xie R, Han J, Liu H, Wang B,
Xie W, Xie W, Zhong G, Chen C, et al: Heterogeneous nuclear
ribonucleoprotein K is associated with poor prognosis and regulates
proliferation and apoptosis in bladder cancer. J Cell Mol Med.
21:1266–1279. 2017. View Article : Google Scholar :
|
|
18
|
Eder S, Arndt A, Lamkowski A, Daskalaki W,
Rump A, Priller M, Genze F, Wardelmann E, Port M and Steinestel K:
Baseline MAPK signaling activity confers intrinsic radioresistance
to KRAS-mutant colorectal carcinoma cells by rapid upregulation of
heterogeneous nuclear ribonucleoprotein K (hnRNP K). Cancer Lett.
385:160–167. 2017. View Article : Google Scholar
|
|
19
|
Matta A, Tripathi SC, DeSouza LV, Grigull
J, Kaur J, Chauhan SS, Srivastava A, Thakar A, Shukla NK, Duggal R,
et al: Heterogeneous ribonucleoprotein K is a marker of oral
leukoplakia and correlates with poor prognosis of squamous cell
carcinoma. Int J Cancer. 125:1398–1406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moumen A, Masterson P, O'Connor MJ and
Jackson SP: hnRNP K: An HDM2 target and transcriptional coactivator
of p53 in response to DNA damage. Cell. 123:1065–1078. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haley B, Paunesku T, Protic M and
Woloschak GE: Response of heterogeneous ribonuclear proteins
(hnRNP) to ionising radiation and their involvement in DNA damage
repair. Int J Radiat Biol. 85:643–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wiesmann N, Strozynski J, Beck C,
Zimmermann N, Mendler S, Gieringer R, Schmidtmann I and Brieger J:
Knockdown of hnRNPK leads to increased DNA damage after irradiation
and reduces survival of tumor cells. Carcinogenesis. 38:321–328.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eder S, Lamkowski A, Priller M, Port M and
Steinestel K: Radiosensitization and downregulation of
heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition
of mitogen/extracellular signal-regulated kinase (MEK) in malignant
melanoma cells. Oncotarget. 6:17178–17191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Strozynski J, Heim J, Bunbanjerdsuk S,
Wiesmann N, Zografidou L, Becker SK, Meierl AM, Gouveris H, Lüddens
H, Grus F and Brieger J: Proteomic identification of the
heterogeneous nuclear ribonucleoprotein K as irradiation responsive
protein related to migration. J Proteomics. 113:154–161. 2015.
View Article : Google Scholar
|
|
25
|
Steinestel K, Lennerz JK, Eder S, Kraft K
and Arndt A: Invasion pattern and histologic features of tumor
aggressiveness correlate with MMR protein expression, but are
independent of activating KRAS and BRAF mutations in CRC. Virchows
Arch. 465:155–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liebau S, Steinestel J, Linta L, Kleger A,
Storch A, Schoen M, Steinestel K, Proepper C, Bockmann J,
Schmeisser MJ and Boeckers TM: An SK3 channel/nWASP/Abi-1 complex
is involved in early neurogenesis. PLoS One. 6:e181482011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuan SL, Fischer S, Hafner S, Wang T,
Syrovets T, Liu W, Tokura Y, Ng DYW, Riegger A, Förtsch C, et al:
Boosting antitumor drug efficacy with chemically engineered
multidomain proteins. Adv Sci (Weinh). 5:17010362018. View Article : Google Scholar
|
|
28
|
Zuo Z, Syrovets T, Wu Y, Hafner S,
Vernikouskaya I, Liu W, Ma G, Weil T, Simmet T and Rasche V: The
CAM cancer xenograft as a model for initial evaluation of MR
labelled compounds. Sci Rep. 7:466902017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tomayko MM and Reynolds CP: Determination
of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother
Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fakhry C, Westra WH, Wang SJ, van Zante A,
Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, et al: The
prognostic role of sex, race, and human papillomavirus in
oropharyngeal and nonoropharyngeal head and neck squamous cell
cancer. Cancer. 123:1566–1575. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Worsham MJ, Stephen JK, Chen KM, Mahan M,
Schweitzer V, Havard S and Divine G: Improved survival with HPV
among African Americans with oropharyngeal cancer. Clin Cancer Res.
19:2486–2492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roychoudhury P and Chaudhuri K: Evidence
for heterogeneous nuclear ribonucleoprotein K overexpression in
oral squamous cell carcinoma. Br J Cancer. 97:574–576. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gao R, Yu Y, Inoue A, Widodo N, Kaul SC
and Wadhwa R: Heterogeneous nuclear ribonucleoprotein K (hnRNP-K)
promotes tumor metastasis by induction of genes involved in
extracellular matrix, cell movement, and angiogenesis. J Biol Chem.
288:15046–15056. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chung IC, Chen LC, Chung AK, Chao M, Huang
HY, Hsueh C, Tsang NM, Chang KP, Liang Y, Li HP and Chang YS:
Matrix metalloproteinase 12 is induced by heterogeneous nuclear
ribonucleoprotein K and promotes migration and invasion in
nasopharyngeal carcinoma. BMC Cancer. 14:3482014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan
PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar
AK, et al: Randomized phase III trial of concurrent accelerated
radiation plus cisplatin with or without cetuximab for stage III to
IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 32:2940–2950.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao X, Feng J, He Y, Xu F, Fan X, Huang W,
Xiong H, Liu Q, Liu W, Liu X, et al: hnRNPK inhibits GSK3β Ser9
phosphorylation, thereby stabilizing c-FLIP and contributes to
TRAIL resistance in H1299 lung adenocarcinoma cells. Sci Rep.
6:229992016. View Article : Google Scholar
|
|
37
|
Yang JH, Chiou YY, Fu SL, Shih IY, Weng
TH, Lin WJ and Lin CH: Arginine methylation of hnRNPK negatively
modulates apoptosis upon DNA damage through local regulation of
phosphorylation. Nucleic Acids Res. 42:9908–9924. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Feliers D, Lee MJ, Ghosh-Choudhury G,
Bomsztyk K and Kasinath BS: Heterogeneous nuclear ribonucleoprotein
K contributes to angiotensin II stimulation of vascular endothelial
growth factor mRNA translation. Am J Physiol Renal Physiol.
293:F607–F615. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sataranatarajan K, Lee MJ, Mariappan MM
and Feliers D: PKCdelta regulates the stimulation of vascular
endothelial factor mRNA translation by angiotensin II through hnRNP
K. Cell Signal. 20:969–977. 2008. View Article : Google Scholar : PubMed/NCBI
|
